Centre of Excellence for Remote and Decentralised Clinical Trials

Trials@Home aims to reshape clinical trial design, conduct and operations, by developing and piloting standards, recommendations and tools for the definition and operationalisation of remote decentralised clinical trials (RDCTs) in Europe.

Centre of Excellence Remote and Decentralised Clinical Trials

Trials@Home aims to reshape clinical trial design, conduct and operations, by developing and piloting standards, recommendations and tools for the definition and operationalisation of remote decentralised clinical trials (RDCTs) in Europe.

*

Key objectives:

  • Defining the best practices for the conduct of RDCTs.

  • Identifying technologies and other operational innovative approaches for RDCTs and selecting the appropriate technology package to be used for the pan-EU pilot.

  • Designing and running a pan-EU pilot, comparing the scientific and operational quality of the RDCT with traditional trial approaches and evaluating the feasibility of the RDCT.

  • Identifying, mapping and analysing the relevant ethical, quality, regulatory, legal and organisational barriers and enablers of RDCTs.

  • Consulting with stakeholders and promoting the outcomes from the Trials@Home consortium through targeted communication, dissemination and training activities.

  • Providing recommendations with supporting tools for implementing RDCTs in Europe and contributing to the update of ICH guidelines on RDCTs.

More
*

About us

*

About RDCT’s

*

About the ESP

News & publications

*

WEBINAR
Innovative Medicines Initiative Trials@Home
A Centre of Excellence for Remote and Decentralised Clinical Trials

Wednesday 24 June 2020, 11-12 CET

This webinar explains in detail what the project is about and will highlight our current Request for Information call.

Click here to watch the video and download the slides

RFI – Identifying existing RCDT solutions

28 April 2020 – Utrecht

In this current stage we are exploring and mapping:

  • existing RDCT technologies across-the-board in any stage of the RCT
  • specific diabetes-oriented technologies, that can be deployed in RDCT approaches.

To support our research we provide the opportunity for companies to submit their technologies through a Request for Information.

Please click here to see if your technology fits one of the categories and submit your information.

Follow us on Twitter
Sign up for our Newsletter